NVZMY NOVOZYMES NOVOZYMES B ADR (DNK
FollowCOM (common)
8 managers (8 13F filers) reported a position in NVZMY shares at 2025-03-31, 26,118 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 8
- 13F filers
- 8
- New
- 0
- Added
- 4
- Reduced
- 3
- Sold out
- 0
- Shares held by filers
- 26,118
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2025
Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | 10,487 | $613K | <0.01% | +132 | 13F-HR/ATimeline |
| Sterling Capital Management LLC | 6,834 | $397K | 0.01% | +579 | 13F-HRTimeline |
| S&CO INC | 4,500 | $261K | 0.02% | 0 | 13F-HRTimeline |
| PNC Financial Services Group, Inc.in group PNC Financial Services Group,… | 1,738 | $102K | <0.01% | -94 | 13F-HRTimelineGroup |
| GAMMA Investing LLC | 1,732 | $101K | 0.01% | +728 | 13F-HR/ATimeline |
| MAR VISTA INVESTMENT PARTNERS LLC | 702 | $41K | <0.01% | -150 | 13F-HRTimeline |
| Brooklyn Investment Group | 68 | $3.95K | <0.01% | -9 | 13F-HRTimeline |
| Copeland Capital Management, LLC | 57 | $3.33K | <0.01% | +12 | 13F-HRTimeline |